Neuropsychiatric HIV - ED screen (depression, mania, psychosis, delirium)
HIV neuropsychiatric · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A new or worsening psychiatric/behavioural change in HIV must trigger an organic workup: delirium, CNS opportunistic infection or lymphoma (toxoplasma, cryptococcus, PML, CMV, neurosyphilis), HIV-associated neurocognitive disorder, metabolic derangement and ART neurotoxicity (efavirenz, rilpivirine, dolutegravir) can all mimic primary psychiatric illness. Depression is common and under-recognised; always screen suicide risk.
Red flags
- Suicidal or homicidal ideation
- Acute delirium
- New psychosis or mania with low CD4 (red flag for CNS OI/lymphoma)
- Focal neurology / headache / fever / seizure
- Rapid cognitive decline; catatonia
- Neuroleptic malignant syndrome / serotonin syndrome
Assessment
Differential diagnosis
- Delirium (toxic/metabolic/infective)
- HIV-associated neurocognitive disorder / dementia
- CNS opportunistic infection or primary CNS lymphoma
- Neurosyphilis
- Major depression
- Bipolar disorder / AIDS mania
- Schizophrenia / new psychosis
- Substance intoxication or withdrawal
- ART neurotoxicity (efavirenz, rilpivirine, dolutegravir)
- Endocrine (hypogonadism, thyroid, adrenal)
Investigations
- Cognitive screen + attention testing (delirium vs dementia vs psychiatric)
- CD4 count + HIV viral load
- Bloods: FBC, U&E, LFT, glucose, Ca, TFT, cortisol if indicated; septic screen
- Syphilis serology
- CT/MRI brain + LP if focal signs/headache/fever/new psychosis (exclude CNS OI/lymphoma)
- Medication review (efavirenz and other CNS-active ART)
- Toxicology
- Validated depression + suicide-risk screen
Management
- Screen for depression and ask directly about suicidal ideation
- Distinguish delirium (acute, fluctuating, inattentive) from primary psychiatric illness - delirium needs a full medical workup
- In new psychosis/mania with low CD4, image the brain + LP to exclude CNS OI/lymphoma BEFORE attributing to a primary psychiatric cause
- Review ART for CNS side effects
- Treat acute agitation with LOW-dose antipsychotic (HIV patients are neuroleptic-sensitive)
- Manage drug interactions (ritonavir/cobicistat raise levels of many psychotropics)
- Involve psychiatry; ensure ART continuation
Drugs & doses
ED generally does not initiate chronic psychotropics - treat reversible/organic causes first
Acute agitation/psychosis: LOW doses of antipsychotics (e.g. risperidone, olanzapine, quetiapine, haloperidol) - HIV patients have heightened neuroleptic sensitivity / EPS risk
Beware interactions: ritonavir/cobicistat (CYP3A4) raise levels of many antipsychotics, benzodiazepines, trazodone and TCAs - start low
Trazodone (low dose) can be used for insomnia; SSRIs are first-line for depression (psychiatry-led)
Valproate can cause hepatotoxicity/cytopenias - caution with HCV or MAC
Specific mg doses not given in source for most agents
Disposition
Psychiatric + medical co-management; admit for suicide risk, delirium, or suspected CNS OI; urgent neuroimaging/LP as indicated; HIV team for ART review.
Complications & pitfalls
- Suicide / self-harm
- Missed CNS opportunistic infection or lymphoma
- Poor ART adherence
- Neuroleptic malignant syndrome / extrapyramidal side effects
- Drug-interaction toxicity
Exam pearls
- A new psychiatric presentation in HIV is organic until proven otherwise - image + LP if low CD4/focal/febrile
- AIDS mania (late-stage, low CD4) is more irritable than euphoric, is chronic, and will not remit untreated
- Depression worsens adherence and mortality - always screen suicide risk
- Efavirenz and dolutegravir can cause depression and neuropsychiatric effects
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.